USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
New Growth Opportunities Emerge in a Strenuous Market
26-Sep-2013
North America
Market Research
NC7B-01-00-00-00
MX00050-NA-MR_17562
This research service pertains to the US market for medical radiopharmaceuticals. A thorough market sizing and forecasting model of market revenue, procedure volumes, and average pricing is included, along with analyses of market trends, drivers and restraints, and the reimbursement and the competitive environments at the total level as well as within each segment. The three market segments considered are diagnostic SPECT radiopharmaceuticals, diagnostic PET radiopharmaceuticals and therapeutic radiopharmaceuticals. The base year of the study is 2012 and the forecast period extends seven years through 2019.
Executive Summary
Executive Summary (continued)
Executive Summary—Market Engineering Measurements
Executive Summary—Market Engineering Measurements (continued)
Executive Summary—CEO’s Perspective
Market Overview—Definitions
Market Overview—Definitions (continued)
Market Overview—Introduction
Market Overview—Distribution Structure and Clinical Applications
Distribution Structure and Clinical Applications Discussion
Market Overview—Scope of Study
Market Overview—Key Questions This Study Will Answer
Market Overview—Segmentation
Market Overview—Segmentation (continued)
Drivers and Restraints
Drivers—Impact and Duration
Drivers Explained
Drivers Explained (continued)
Drivers Explained (continued)
Drivers Explained (continued)
Drivers Explained (continued)
Restraints—Impact and Duration
Restraints Explained
Restraints Explained (continued)
Restraints Explained (continued)
Restraints Explained (continued)
Restraints Explained (continued)
Restraints Explained (continued)
Total Medical Radiopharmaceuticals Market— Introduction
Total Medical Radiopharmaceuticals Market— Introduction (continued)
Market Engineering Measurements
Market Engineering Measurements (continued)
Forecast Assumptions
Total Medical Radiopharmaceuticals Market—Revenue Forecast
Revenue Forecast Discussion
Revenue Forecast Discussion (continued)
Total Medical Radiopharmaceuticals Market—Revenue Forecast by Segment
Revenue Forecast by Segment Discussion
Radiopharmaceutical Reimbursement—Introduction
Reimbursement of Procedures Involving Use of Radiopharmaceuticals
Reimbursement of Procedures Involving Use of Radiopharmaceuticals (continued)
Reimbursement of Procedures Involving Use of Radiopharmaceuticals (continued)
Reimbursed Radiopharmaceuticals Billing Codes
Reimbursed Radiopharmaceuticals Billing Codes (continued)
Reimbursed Radiopharmaceuticals Billing Codes (continued)
Reimbursed Radiopharmaceuticals Billing Codes (continued)
Key Industry Participants and Main Product Lines
Competitive Analysis—Market Share
Market Share Analysis
Radiopharmacy Facility Landscape
Competitive Environment
Competitive Factors and Assessment
Diagnostic SPECT Radiopharmaceuticals Segment Breakdown
Diagnostic SPECT Radiopharmaceuticals Segment—Market Engineering Measurements
Diagnostic SPECT Radiopharmaceuticals Segment—Revenue Forecast
Revenue Forecast Discussion
Revenue Forecast Discussion (continued)
Diagnostic SPECT Radiopharmaceuticals Segment—Procedure Volume Forecast
Procedure Volume Forecast Discussion
Diagnostic SPECT Radiopharmaceuticals Segment—Pricing Trends and Forecast
Pricing Trends and Forecast Discussion
Competitive Analysis—Market Share
Market Share Analysis
Diagnostic PET Radiopharmaceuticals Segment Breakdown
Diagnostic PET Radiopharmaceuticals Segment—Market Engineering Measurements
Diagnostic PET Radiopharmaceuticals Segment—Revenue Forecast
Revenue Forecast Discussion
Diagnostic PET Radiopharmaceuticals Segment—Procedure Volume Forecast
Procedure Volume Forecast Discussion
Procedure Volume Forecast Discussion (continued)
Diagnostic PET Radiopharmaceuticals Segment—Pricing Trends and Forecast
Pricing Trends and Forecast Discussion
Competitive Analysis—Market Share
Market Share Analysis
Radioimmunotherapy Agents Segment—Background
Radioimmunotherapy Agents Segment—Introduction
Radioimmunotherapy Agents Segment Breakdown
Radioimmunotherapy Agents Segment—Market Engineering Measurements
Radioimmunotherapy Agents Segment—Revenue Forecast
Revenue Forecast Discussion
Revenue Forecast Discussion (continued)
Revenue Forecast Discussion (continued)
Revenue Forecast Discussion (continued)
Revenue Forecast Discussion (continued)
The Last Word—Three Big Predictions
Legal Disclaimer
Market Engineering Methodology
Learn More—Next Steps
Speak directly with our analytics experts for tailored recommendations.
Recent related Life Sciences research
13 Jan 2025 | Global | Market Outlook
Top 6 Growth Opportunities for the Digital Health Industry, 2025
Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...
17 Dec 2024 | Global | Market Research
Cybersecurity in Healthcare, United States, 2024
Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...
12 Dec 2024 | Global | Market Outlook
Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025
Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...
05 Dec 2024 | Global | Frost Radar
Frost Radar™: Enterprise Conversational AI in Healthcare, 2024
This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-care, a...
27 Nov 2024 | Global | Market Research
Generative AI in Payer and Provider IT Transformation, Global, 2024-2029
The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Nadim Daher |
| Industries | Healthcare |
| WIP Number | NC7B-01-00-00-00 |
| Is Prebook | No |
US Medical Radiopharmaceuticals Market
$4,950.00
Special Price $3,712.50 save 25 %